價(jià)格 | ¥593 | ¥1490 | ¥2320 |
包裝 | 1mg | 5mg | 10mg |
最小起訂量 | 1mg |
發(fā)貨地 | 上海 |
更新日期 | 2024-09-29 |
中文名稱(chēng):化合物 TP0463518 | 英文名稱(chēng):TP0463518 |
CAS:1558021-37-6 | 品牌: TargetMol |
產(chǎn)地: 美國(guó) | 保存條件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
純度規(guī)格: 99.43% | 產(chǎn)品類(lèi)別: 抑制劑 |
貨號(hào): T5392 |
名稱(chēng) | TP0463518 |
描述 | TP-0463518 is a highly potent HIF prolyl hydroxylase (PHD) inhibitor (IC50s: 13 nM and 18 nM for human and rat PHD2, respectively). |
激酶實(shí)驗(yàn) | The PHDs inhibition studies were performed using fluorescence polarization.FITC-HIF and 2-oxoglutarate were mixed with enzyme solution in a reaction buffer (20 mM Tris-HCl [pH 7.5],5 mM KCl,1.5 mM MgCl2,10 μM FeSO4,2 mM ascorbic acid,1 mM DTT) with or without various concentrations of TP0463518.The concentrations of FITC-HIF and 2-oxoglutarate were twice the Km values of each enzyme.The reaction temperature was 30?C,and the reaction time was optimized to each PHD enzyme to obtain the initial velocity (9 to 20 min).At the end of the reaction,a stop solution containing 20 mM of EDTA and anti-hydroxylated HIF antibody was added to the reaction buffer.Then,the fluorescence (ex: 480 nm,em: 535 nm) was measured using EnVision to calculate the millipolarization (mP) value.The mP values and the corresponding hydroxylated HIF concentration were proportional,so we used the mP values as the activities.The IC50 values were calculated using SAS version 9.2 using a nonlinear least-squares method.To determine the mode of inhibition,the activity of PHD2 was measured with various concentrations of 2-oxoglutarate (0.025 to 8 μM) and TP0463518 (0 to 40 μM).Then the apparent Vmax and Km corresponding to each TP0463518 concentration were compared.The mode of inhibition was confirmed using a double reciprocal plot. |
動(dòng)物實(shí)驗(yàn) | Nine-week-old Balb/c mice were randomly assigned to a vehicle or a 5 to 40 mg/kg dose of TP0463518 group. The mice were orally treated with 0.5% methylcellulose or a TP0463518 dosing suspension. Blood was collected at 6 h after administration from the orbital plexus under deep anesthesia, and euthanasia was performed without awakening. An aliquot of blood was mixed with EDTA, and the remaining blood sample was left to stand at room temperature for 15 min. The samples were then centrifuged (2130 x g for 10 min at 4°C) to prepare the plasma and serum. |
體外活性 | TP0463518 競(jìng)爭(zhēng)性抑制人類(lèi) PHD2,Ki 值為 5.3nM。此外,TP0463518 也對(duì)人類(lèi) PHD1/3 表現(xiàn)出抑制作用,IC50 值分別為 18 nM 和 63 nM,以及對(duì)猴子 PHD2 的抑制作用,IC50 值為 22nM。 |
體內(nèi)活性 | 在正常的小鼠和大鼠中,TP0463518在5mg/kg和20mg/kg的劑量下顯著提高了血清EPO水平。在5/6腎切除的慢性腎臟病模型大鼠中,TP0463518以10mg/kg的劑量也增加了血清EPO水平,血清EPO與血清TP0463518水平的相關(guān)系數(shù)為0.82。TP0463518的半衰期為5.2小時(shí),且在5mg/kg的劑量下增加了EPO的曲線(xiàn)下面積(AUC)。 |
存儲(chǔ)條件 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
溶解度 | DMSO : 110 mg/mL (254.73 mM) |
關(guān)鍵字 | TP0463518 | HIF-PH | TP-0463518 | HIFs | TP 0463518 | inhibit | Inhibitor | HIF/HIF Prolyl-Hydroxylase | Hypoxia-inducible factors |
相關(guān)產(chǎn)品 | Hydralazine hydrochloride | Hydroxycitric acid tripotassium hydrate | Chlorogenic Acid | Glucosamine | 1,4-DPCA | DMOG | Glucosamine sulfate | Deferoxamine Mesylate | Glucosamine hydrochloride | Vadadustat | Minocycline hydrochloride | Oltipraz |
相關(guān)庫(kù) | 抑制劑庫(kù) | 經(jīng)典已知活性庫(kù) | 已知活性化合物庫(kù) | 抗癌細(xì)胞代謝庫(kù) | 代謝化合物庫(kù) | 抗衰老化合物庫(kù) | HIF-1化合物庫(kù) | 谷氨酰胺代謝化合物庫(kù) | NO PAINS 化合物庫(kù) | 糖代謝化合物庫(kù) |
成立日期 | 2013-04-18 (12年) | 注冊(cè)資本 | 566.265100萬(wàn)人民幣 |
員工人數(shù) | 100-500人 | 年?duì)I業(yè)額 | ¥ 1億以上 |
主營(yíng)行業(yè) | 天然產(chǎn)物,生化試劑,分子生物學(xué),分子砌塊,生物技術(shù)服務(wù) | 經(jīng)營(yíng)模式 | 貿(mào)易,工廠(chǎng),試劑,定制,服務(wù) |
產(chǎn)品名稱(chēng) | 價(jià)格 | 公司名稱(chēng) | 報(bào)價(jià)日期 | |
---|---|---|---|---|
詢(xún)價(jià) |
VIP1年
|
青島愷潤(rùn)生物醫(yī)藥科技有限公司
|
2024-11-02 | |
¥198 |
VIP12年
|
上海陶術(shù)生物科技有限公司
|
2024-10-18 | |
詢(xún)價(jià) |
VIP1年
|
陜西西化化學(xué)工業(yè)有限公司
|
2024-10-15 | |
詢(xún)價(jià) |
VIP11年
|
四川省維克奇生物科技有限公司
|
2024-10-29 | |
¥2059.90 |
VIP1年
|
上海阿拉丁生化科技股份有限公司
|
2024-08-16 |